National Institute for Biological Standards and Control Assuring the quality of biological medicines Proposal for a Hepatitis A genotype panel Rob Anderson.

Slides:



Advertisements
Similar presentations
Kathrine Stene-Johansen NIPH
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
Development of a Panel for Dengue Virus Maria Rios, PhD CBER/FDA Blood Products Advisory Committee Meeting December 14, 2010.
NIBSC Multiplex Proficiency Panel - A multicentre study
Proposal to Prepare Reference Panels & Standards for Hepatitis E Virus
XX. SoGAT Meeting Warsaw 12./13. June 2007 IU vs. NAT-Detectable Units Albrecht Gröner CSL Behring Virology Marburg, Germany.
Emerging Infectious Disease (EID) involving Respiratory Tract
Structure Determination by NMR I. Choose a biologically important question. II. Determine if and how NMR can address the question. III. Synthesize or extract.
Overview of Molecular Epidemiological Methods for the Subtyping and Comparison of Viruses Derek Wong
Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Yi-Chen Yang, Drug Biology Division Bureau of Food and Drug Analysis Department of Health, Taiwan Collaborative study for establishment of the first national.
1 Institute for Clinical Microbiology and Immunology,St. Gallen, Switzerland 2 Swedish Institute for Infectious Disease Control, Karolinska Institutet,
Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:
HEV in Belgium: An import infection or an emerging viral zoonosis? I.Micalessi, I.Thomas, B. Brochier National Center of Viral Hepatitis Rue Juliette Wytsmanstraat.
Hepatitis viruses. Features of structure and main biological properties Vinnitsa National Pirogov Memorial Medical University / Department of microbiology.
Carolyn A. Ragland August Hepatitis C *Paraenterally transmitted Contact with infected blood / blood products Blood transfusions – no longer the.
بسم الله الرحمن الرحيم والصلاة والسلام على سيد المرسلين.
Dengue Virus and Its Risk to the U.S. Blood Supply
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
HIV Testing CDC power point edited by M. Myers
Full characterization of HAV RNA window period positive blood donations in Germany SoGAT XVIII Bethesda.
Viral Hepatitis A “Infectious” “Serum” Viral hepatitis Enterically transmitted Parenterally transmitted F, G, ? other E NANB BD C.
21 August 2015 Samreen Ijaz Virus Reference Department Health Protection Agency Indigenous HEV infection in the UK: a hazard for blood donation?
BioLife Plasma Services Experience with HBV NAT Testing
Detection of parvovirus B19 and novel human parvoviruses in high-risk individuals Ashleigh Manning 1, Kate Templeton 2, Ed. Gomperts 3, Peter Simmonds.
FDA’s Current Considerations of Parvovirus B19 Nucleic Acid Testing (NAT) Mei-ying W. Yu, PhD Division of Hematology CBER/FDA Extraordinary SoGAT Meeting.
(+) Stranded RNA Viruses III
DR. MOHAMMED ARIF. ASSOCIATE PROFESSOR CONSULTANT VIROLOGIST HEAD OF THE VIROLOGY UNIT Enterically transmitted hepatitis (Water-borne hepatitis)
DEVELOPMENT OF THE TOOLS FOR PCR-DETECTION OF HEPATITIS A AND C VIRUSES IN INTRAHOSPITAL VIRAL CONTAMINATION RESEARCH. 1 D. I. Ivanovsky Virology Institute,
Lara Isobel Compston, Daniel Candotti, Jean-Pierre Allain
Evaluation of Viral Clearance Studies
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
E A 1 Parvovirus B19 and HAV Screening of Whole Blood Donations SL Stramer, KL Kane, ML Beyers, RY Dodd, American Red Cross and RIF Smith, National.
Level of viraemia and genotype characteristics of Parvo B19 in blood donors and patients Brojer E, Grabarczyk P Depatment of Immuhematology Institute of.
Commercial Assays and Detection of Parvovirus B19 genotypes Dr Sally A. Baylis, Division of Virology NIBSC.
Parvovirus B19 Genotype 2 Plasma, Sourced from the US Dr Sally A. Baylis, Division of Virology NIBSC.
SoGAT XVII/Paris, 2004 Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening Michael Chudy, Paul-Ehrlich-Institut Division of Virology,
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
Current Status of Issues Related to West Nile virus testing and donor screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
Progress in West Nile virus Testing and Donor Screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
Genetic variability of HCMV strains isolated from Polish pregnant women, their fetuses and newborns 3rd International Conference on Clinical Microbiology.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
Active B19 virions production in hepatoblastoma and hepatocarcinoma cell lines: amplification and genomic stability. Op de beeck A. 1, Draps M.-L. 1, Baurin.
Hepatitis. Hepatitis is an inflammation of the liver. Hepatitis is caused by several types of viruses as well as drug and chemical toxicity.
16/3/20091Dr. Salwa Tayel. 16/3/20092Dr. Salwa Tayel Viral Hepatitis.
19 September 2006 Gaithersburg, MD David Peretz M.Sc., D.Sc. Senior Scientist CHIRON Submission To FDA TSE Advisory Committee Meeting.
OnSite HEV Rapid Test.
Preparation of HBV DNA reference standards and the experience of HBV NAT in Taiwan Dr. Hwei-Fang Cheng Department of Health, Taiwan.
NIBSC 2 March 2007 The European Directorate for the Quality of Medicines and Health Care issues of concern regarding the detection of B19 in blood:plasma.
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
Evaluation of Viral Clearance Studies Mahmood Farshid, Ph.D. Div. Of Hematology OBRR/ CBER/FDA.
An Overall View of Standardization May 26, 2004 Indira Hewlett, Ph.D. CBER/FDA.
Validation of Nucleic Acid and Serological Tests to Screen Blood and Plasma donors for Acute infection with West Nile virus Hira Nakhasi, Ph.D. Director,
Novel and Related Variant Parvoviruses in Human Plasma Jacqueline Fryer and Sally Baylis National Institute for Biological Standards and Control Eric Delwart.
Enterically transmitted hepatitis (Water-borne hepatitis)
Superv. : Dr. Gomaa Abdelrahim Abdullalim By Khaled Al-Duraimeeh Abdullah Al-Sgair Majmaah University Collage of science in Al- Zulfi Medical.
HEPATITIS C VIRUS INFECTION AMONG PATIENTS AT HOSPITAL TENGKU AMPUAN AFZAN, KUANTAN: GENOTYPES DISTRIBUTION AND RNA SEQUENCE VARIATION.
February 24, 2016 | 1 Paul Strengers MD, FFPM Sanquin Blood Supply Amsterdam The Netherlands Risk assessment schemes: Impact of.
SOGAT Presence (absence) of genotype 2 and 3 Erythrovirus DNA in manufacturing plasma Theo Cuypers, Marco Koppelman, Margret Sjerps, Henk Reesink.
Dawit Assefa Ethiopia Health and Nutrition Research Institute Dawit Assefa Ethiopia Health and Nutrition Research Institute Evaluation of an in-house HIV.
Human Parvovirus PARV4 in Blood and Plasma Products
*Dr. Mushtak T. S Al-Ouqaili **Dr. Yasin Hamad Majeed
Testing for Parvovirus B19 - Broadening the Assay to Cover Variants
Harvey Holmes, Clare Morris and Neil Berry Division of Retrovirology
Update on CBER HIV-1 Subtype panel
HEPATITIS C BY MBBSPPT.COM
Distributions of parvovirus B19 genotype 1-3 in blood donations
Comparison of a commercial and ‘in house’ assay for B19 DNA
Presentation transcript:

National Institute for Biological Standards and Control Assuring the quality of biological medicines Proposal for a Hepatitis A genotype panel Rob Anderson.

Hepatitis A Hepatitis A (HAV) is a non-enveloped, positive stranded RNA virus HAV is a member of the genus hepatovirus of the picornavirus family The genome is approximately 7.5kBp in length The genome has two UTRs The 5 UTR is longer, being around BP in length, compared to that of the 3 UTR, which is around 40-80bp. Like most positive sense RNA genomes, the genetic material alone is infectious

Hepatitis A Nucleotide sequence analysis of HAV has allowed classification of the virus into six different genotypes Genotypes I, II, and III are associated with human infections whereas genotypes IV, V and VI cause infections in simians Subtype IA appears to be responsible for the majority of HAV cases worldwide, whereas subtype IB viruses tend to be found only in the Mediterranean region There is no published clinical correlation to genotype

Hepatitis A Disease Hepatitis A infection-is an acute, self-limiting infection of the liver without a chronic stage usually transmitted by the faecal-oral route The infection may be asymptomatic or may cause an acute hepatitis syndrome of varying degrees of severity up to and including fulminant hepatitis. Peak viraemia is seen days after infection This means that it is possible for donations from asymptomatic individuals to occur as there is a short period (several days) between viraemia and symptoms Hepatitis A can be transmitted by the parenteral route but very rarely by blood and blood products

Screening for Hepatitis A HAV is rarely transmitted by transfusion and is much rarer in whole blood donors than B19 (estimated to be between 1 : donors) Transmission by pooled derivatives has occurred in the case of FVIII – Chudy et al. J Med Virol (1999) 57: 91-9 Principle reason is that HAV is not inactivated during the manufacturing process and is resistant to detergent, acid (pH 1), solvents, drying, and temperatures up to 60 o C Therefore NAT is performed for plasma intended for manufacture of blood products/derivatives

HAV assay kits Two principle manufacturers of diagnostic HAV assay kits – LightCycler Hepatitis A virus quantification kit (Roche Diagnostics) – RealArt HAV LC RT PCR kit (Qiagen artus GmbH) Study was performed and published – G Sánchez et al. J Virol Methods (2006) 132: They used HM-175 (Genotype IB) and HAS15 (genotype IA) Conclusion was that both assays are very suitable for detection and quantification of the most prevalent HAV subtypes However not all genotypes may be picked up as sensitively as each other

27 HAV isolates with complete sequence information. Endo et al. Virus Research 126 (2007) 116–127

Percentage comparison of the complete ORF nucleotide and amino acid sequence identities of 26 known HAV isolates Endo et al. Virus Research 126 (2007) 116–127

Proposal As many samples of Hepatitis A positive serum/plasma as possible covering all of the identified genotypes Amplification (if possible) in animals - macaques at the HPA NIBSC co-ordinated collaborative study to assess and validate the panel Genotype panel as a catalogue item analogous to the Hepatitis C panel The panel will be available to kit manufacturers and others intending to validate in-house assays for HAV

Contact address Thank you for your help.